TABLE 4.
Clinical scenarios.
| Characteristics | Points | ||
| Case 1 | Age (years) | 75 | 48 |
| Body mass index (kg/m2) | 34 | 55 | |
| NYHA functional class | IV | 100 | |
| Use of diuretics | yes | 29 | |
| LA volume index (ml/m2) | 40 | 30 | |
| sPAP (mmHg) | 54 | 25 | |
| NT-proBNP/100 (pg/ml) | 2850 | 88 | |
| HF hospitalizations (n) | 5 | 48 | |
| Total points | 423 | ||
| Linear predictor | 3 | ||
| Survival | 20% 2-Year survival | ||
| Case 2 | Age (years) | 75 | 48 |
| Body mass index (kg/m2) | 34 | 55 | |
| NYHA functional class | I | 0 | |
| Use of diuretics | yes | 29 | |
| ‘LA volume index (ml/m2) | 30 | 22 | |
| sPAP (mmHg) | 46 | 20 | |
| NT-proBNP/100 (pg/ml) | 600 | 18 | |
| HF hospitalizations (n) | 1 | 25 | |
| Total points | 217 | ||
| Linear predictor | 1.2 | ||
| Survival | 80% 2-Year survival | ||
NYHA, New York Heart Association; LA, left atrial; sPAP, pulmonary arterial systolic pressure; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; HF, heart failure.